Caixin
Oct 31, 2021 08:00 AM

Hubei Jumpcan Pharmaceutical Co.,Ltd.’s Net Profit Rose 32.5% in First Three Quarters of 2021

Hubei Jumpcan Pharmaceutical Co.,Ltd. (湖北济川药业股份有限公司) (600566.SH) reported a net profit of 1.3 billion yuan in the first three quarters of 2021, up 32.5% year-on-year.

Meanwhile, the company posted 5.4 billion yuan in revenue, up 25.4% year-on-year.

At the end of the reporting period, it had 11.5 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 24.3%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST